IP Library Granted Patent US 7,824,867
Granted Patent B2
US 7,824,867 · App. 12/119,793 · Granted Nov 2, 2010

Rapid ELISA processes and related compositions

Assignee: GenScript Holdings (Hong Kong) Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,824,867
App. No.
12/119,793
Granted
Nov 2, 2010
Kind
B2
Abstract

The present invention provides improved and rapid detection methods for an antigen such as a chemical compound, a peptide, a nucleic acid, or a protein released from cells or virus particles in situ. The detection time for an antigen can be dramatically reduced relative to conventional technologies. The technology can particularly be used, for example, to modify and reduce the detection time significantly in traditional ELISA, and also Western blot or Dot blot assays. The improved ELISA method is rapid, economical, reproducible, simple and automatable. Also provided are compositions and kits for using the improved ELISA methods for the rapid detection of antigens.

Claims (37)

1. A method for performing a rapid enzyme-linked immunosorbent assay (ELISA), comprising the steps of:

(a) coating a solid phase with an antigen dissolved in a quick coating buffer for between about two to twenty minutes, wherein the quick coating buffer comprises water and a metal hydroxide selected from the group consisting of sodium hydroxide, potassium hydroxide and rubidium hydroxide;

(b) blocking the solid phase with a blocking reagent dissolved in a quick blocking buffer for between about two to ten minutes, wherein the quick blocking buffer comprises a metal hydroxide selected from the group consisting of sodium hydroxide, potassium hydroxide and rubidium hydroxide; and

(c) (i) incubating the solid phase with a primary detection agent in solution;

washing the solid phase to remove any unbound primary detection agent; and

detecting the presence of an agent bound on the solid phase with a detection system that detects the bound primary detection agent; or

(ii) incubating the solid phase with a primary detection agent in solution;

washing the solid phase to remove any unbound primary detection agent;

incubating the solid phase with a secondary detection agent in solution;

washing the solid phase to remove any unbound secondary detection agent; and

detecting the presence of an agent bound on the solid phase with a detection system that detects the bound secondary detection agent; or

(iii) incubating the solid phase simultaneously with a primary detection agent and a secondary detection agent in solution;

washing the solid phase to remove any unbound primary detection agent and secondary detection agent; and

detecting the presence of an agent bound on the solid phase with a detection system that detects the bound secondary detection agent; or

(iv) incubating the solid phase with a primary detection agent in solution;

washing the solid phase to remove any unbound primary detection agent; and

incubating the solid phase with a secondary detection agent in solution;

washing the solid phase to remove any unbound secondary detection agent; and

incubating the solid phase with a tertiary detection agent in solution; and

washing the solid phase to remove any unbound tertiary detection agent; and

detecting the presence of an agent bound on the solid phase with a detection system that detects the bound tertiary detection agent; or

(v) incubating the solid phase simultaneously with a primary detection agent, a secondary detection agent and a tertiary detection agent in solution;

washing the solid phase to remove any unbound primary detection agent, secondary detection agent and tertiary detection agent; and

detecting the presence of an agent bound on the solid phase with a detection system that detects the bound tertiary detection agent.

2. The method according to claim 1 , wherein the solid phase is coated with an antigen in the quick coating buffer for about five minutes and the solid phase is blocked with the blocking reagent in the quick blocking buffer for about five minutes.

3. The method according to claim 1 , wherein the blocking reagent is selected from the group consisting of non-fat milk, casein, BSA, fish gelatin and other chemical reagents.

4. The method according to claim 1 , wherein said metal hydroxide concentration in the quick coating buffer ranges from between about 0.004 g/l to 40 g/l of buffer, and wherein the quick coating buffer has a pH ranging from between about 10.0 to 14.0.

5. The method according to claim 4 , wherein the metal hydroxide in the quick coating buffer is sodium hydroxide.

6. The method according to claim 5 , wherein the sodium hydroxide concentration is about 4 g/l of buffer, and wherein the quick coating buffer has a pH of about 13.0.

7. The method according to claim 1 , wherein said metal hydroxide a concentration in the quick blocking buffer ranges from between about 0.0056 g/l to 56 g/l of buffer, and wherein the quick blocking buffer has a pH ranging from between about 10.0 to 14.0.

8. The method according to claim 7 , wherein the metal hydroxide in the quick blocking buffer is potassium hydroxide.

9. The method according to claim 8 , wherein the potassium hydroxide concentration is about 5.6 g/l of buffer, and wherein the quick blocking buffer has a pH of about 13.0.

10. The method according to claim 1 , wherein said detection system detects the bound detection agent by measuring signals selected from the group consisting of ultraviolet light, fluorescence, luminescence, colorimetric signals and other signals capable of detecting the bound detection agent.

11. The method according to claim 1 , wherein the detection agent can be labeled or unlabeled, said detection agent selected from the group consisting of avidin, strepavidin, a chemical molecule, a peptide molecule, a protein molecule, an RNA molecule, a DNA molecule, an antibody, a fragment of an antibody, a recombinant antibody, a bacterial cell, a virus particle, a cell and a particle.

12. The method according to claim 11 , wherein the protein molecule is selected from the group consisting of protein A, protein G, protein L, protein A/G and other antibody-binding polypeptides.

13. The method according to claim 11 , wherein the detection agent is labeled, said label is selected from the group consisting of an enzyme; radioactive isotope; fluorochrome; lumichrome and biotin.

14. The method according to claim 13 , wherein the enzyme is selected from the group consisting of horseradish peroxidase, alkaline phosphatase and beta-galactosidase.

Assignments (6)
CHANGE OF NAME Recorded Apr 9, 2021
From: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
To: NANJING GENSCRIPT BIOTECH CO., LTD.
Reel/Frame 055886/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2011
From: GENSCRIPT (HONG KONG) LIMITED
To: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
Reel/Frame 026403/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2010
From: JINSITE SCIENCE & TECHNOLOGY (NANJING) CO., LTD.
To: GENSCRIPT (HONG KONG) LIMITED
Reel/Frame 025516/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2009
From: GENSCRIPT CORPORATION
To: JINSITE SCIENCE & TECHNOLOGY (NANJING) CO., LTD.
Reel/Frame 022669/0990 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2008
From: WANG, ZHUYING; ZHANG, FANG LIANG; BAI, TAO
To: JINSITE SCIENCE & TECHNOLOGY (NANJING) CO., LTD.
Reel/Frame 021948/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2008
From: WANG, ZHUYING; ZHANG, FANG LIANG; BAI, TAO
To: GENSCRIPT CORPORATION
Reel/Frame 020942/0403 →
Continuity (2)
Provisional Application 6092920600 · Jun 18, 2007
Related Publication 20080311602A1 · Dec 18, 2008